COM:MAGENTATX
Dianthus Therapeutics, Inc.
- Stock
Last Close
0.76
11/09 20:00
Market Cap
42.44M
Beta: -
Volume Today
375.91K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
net income | -9.43M - | -35.49M 276.32% | -57.52M 62.06% | -76.77M 33.48% | -74.94M 2.39% | -71.14M 5.07% | -76.46M 7.49% | |
depreciation and amortization | 6K - | 376K 6,166.67% | 875K 132.71% | 1.84M 110.63% | 1.98M 7.33% | 2.02M 2.12% | 1.93M 4.70% | |
deferred income tax | 67K - | |||||||
stock based compensation | 662K - | 2.26M 241.24% | 10.70M 373.79% | 10.00M 6.56% | 9.94M 0.60% | 10.31M 3.69% | 7.02M 31.89% | |
change in working capital | 1.60M - | 1.32M 17.42% | 4.17M 216.69% | 8.83M 111.57% | -1.19M 113.43% | -1.53M 28.67% | -2.70M 77.06% | |
accounts receivables | ||||||||
inventory | ||||||||
accounts payables | 1.01M - | -1.13M 211.83% | 2.50M 322.22% | 145K 94.20% | 948K 553.79% | -720K 175.95% | -801K 11.25% | |
other working capital | 590K - | 2.44M 314.07% | 1.67M 31.48% | 8.69M 418.88% | -2.13M 124.57% | -806K 62.23% | -1.90M 135.86% | |
other non cash items | 638K - | 9.28M 1,353.76% | -190K 102.05% | -1.01M 431.05% | 180K 117.84% | 803K 346.11% | 3.13M 289.54% | |
net cash provided by operating activities | -6.53M - | -22.26M 240.99% | -41.89M 88.14% | -57.10M 36.33% | -64.02M 12.12% | -59.53M 7.02% | -67.09M 12.70% | |
investments in property plant and equipment | -139K - | -2.20M 1,482.01% | -7.67M 248.89% | -3.06M 60.11% | -400K 86.93% | -1.26M 216% | -314K 75.16% | |
acquisitions net | ||||||||
purchases of investments | -84.04M - | -144.37M 71.78% | -95.73M 33.69% | -45.31M 52.67% | -69.50M 53.39% | |||
sales maturities of investments | 148.96M - | 85.50M 42.60% | 90M 5.26% | 60M 33.33% | ||||
other investing activites | -135K - | 12K 108.89% | ||||||
net cash used for investing activites | -139K - | -2.33M 1,579.14% | -91.70M 3,829.01% | 1.53M 101.67% | -10.63M 794.19% | 43.43M 508.35% | -9.81M 122.59% | |
debt repayment | ||||||||
common stock issued | 13K - | 4K 69.23% | 93M 2,324,900% | 60.87M 34.54% | 64.86M 6.55% | 2.90M - | ||
common stock repurchased | -107K - | -213K 99.07% | -88K 58.69% | 104K - | 141K 35.58% | 115K 18.44% | ||
dividends paid | ||||||||
other financing activites | 10.80M - | 71.69M 563.54% | 49.23M 31.33% | 1.42M 97.11% | 2.77M 95.01% | 89.46M 3,123.78% | -141K 100.16% | |
net cash used provided by financing activities | 10.71M - | 71.49M 567.41% | 142.15M 98.85% | 62.30M 56.17% | 67.74M 8.74% | 89.60M 32.27% | 2.88M 96.79% | |
effect of forex changes on cash | ||||||||
net change in cash | 4.04M - | 46.89M 1,059.76% | 8.56M 81.75% | 6.73M 21.41% | -6.92M 202.87% | 73.50M 1,162.26% | -74.02M 200.72% | |
cash at beginning of period | 500K - | 4.51M 802.60% | 51.57M 1,042.63% | 60.13M 16.60% | 66.85M 11.19% | 59.93M 10.35% | 133.43M 122.64% | |
cash at end of period | 4.54M - | 51.40M 1,031.45% | 60.13M 16.97% | 66.85M 11.19% | 59.93M 10.35% | 133.43M 122.64% | 59.41M 55.48% | |
operating cash flow | -6.53M - | -22.26M 240.99% | -41.89M 88.14% | -57.10M 36.33% | -64.02M 12.12% | -59.53M 7.02% | -67.09M 12.70% | |
capital expenditure | -139K - | -2.20M 1,482.01% | -7.67M 248.89% | -3.06M 60.11% | -400K 86.93% | -1.26M 216% | -314K 75.16% | |
free cash flow | -6.67M - | -24.46M 266.86% | -49.56M 102.59% | -60.16M 21.40% | -64.42M 7.08% | -60.80M 5.63% | -67.40M 10.87% |
All numbers in (except ratios and percentages)